Eugene Zhou focuses on inflammation resolution and lipid mediator signaling. He applies transcriptomics, lipidomics, and pharmacology to link immune activity with degenerative disease and cancer, and evaluates pro‑resolving small‑molecule analogs with quantitative biomarkers in preclinical models.